|
|
||||||||
DISCOVERY! |
Poliklinik für Zahnerhaltung und Parodontologie, Klinikum der Universität, D-93042 Regensburg, Germany; Gottfried.Schmalz{at}klinik.uni-regensburg.de
KEY WORDS: dental materials toxicity biocompatibility cell culture standardization
| THE FIRST STEPS |
|---|
|
|
|---|
However, the number of publications slowly increased until the middle of the last century, but the scope of biological aspects was restricted to the adverse effects of dental materials. Two main streams of interest could be observed. The first one concentrated on local effectse.g., pulp problems associated with dental filling materials such as silicate cements (Fasoli, 1924), based on the clinical observations of pulp necroses under silicate fillings. In the second stream, the systemic adverse effects of one materialnamely, amalgamwas the center of not only scientific (and non-scientific) reports but also of strongly emotional public discussions.
| DEVELOPING NEW TECHNIQUES |
|---|
|
|
|---|
The second main stream concentrated on the evaluation of more basic biological properties, e.g., using cell culture techniques. These methods became available to dental research during the 1950s, and one of the pioneers in this field was H. Kawahara and his team in Japan (Kawahara et al., 1955). In Europe, similar studies were initiated (Maizumi and Sauerwein, 1962).
| MATERIALS SCIENCE TOXICOLOGY |
|---|
|
|
|---|
The Director of and the driving force behind MST was J. Autian. He started his career with a study on the biocompatibility of synthetic high-molecular-weight polymer ("plastic") materials usede.g., in tubings and syringe hubs (Autian and Brewer, 1958). Analysis of his data suggested that problems may occur when a plastic material is used in a pharmaceutical application without adequate testing being carried out first. In 1960, at the University of Texas, Austin (School of Pharmacy), he continued his work on the toxicity and drug interactions of plastic medical materials. During this time, the field of materials toxicity attracted post-doctorate and graduate students, and test methods were developed such as the agar diffusion test, which today is included in most biological standards. Attention was also paid to the elution and biological effects of plasticizers, e.g., phthalate esters, a topic which has kept its significance even today. In 1967, Autian was appointed a professor in the Colleges of Pharmacy and Dentistry and director of the MST laboratory.
MST was divided into four sections (heads in parenthesis), reflecting its different roots: (1) physical chemistry (L. Nunez), (2) cellular toxicology (E.O. Dillingham), (3) animal toxicology (H. Lawrence), and (4) pathology (J. Turner). Teaching obligations in both Pharmacy and Dentistry were a further basis for intensive interdisciplinary exchange. A graduate program in toxicology and materials science (MS and PhD) had been established. From 1968-1986, basic aspects of toxicity testing of biomaterials were established and different tests developed, refined, or adjusted from general toxicology to be used for materials testing, e.g., the agar diffusion method, the (static) hemolysis test, and the inhibition of cell growth test (all in vitro), or the rabbit intramuscular implantation test and LD50 tests (in vivo). Most of these tests have become classics, and many are still in use today (Schmalz, 1997). Furthermore, the idea of the structure-related activity of chemicals was applied to toxicology with substances used in plastic medical devices, like acrylates and methacrylates (Dillingham et al., 1983). In the 1970s, MST received a contract from FDA to develop tests for the safety of materials to be used in medical applications. A set of tests known as the "MST Primary Acute Toxicity Screening Program" was devised, based on the philosophy that safety testing of materials must not be based on a single test alone, but on a set of tests (Autian, 1977).
MST trained people from industry, and visiting scientists from all over the world, including the author of this article, were invited every year, and thus the idea of materials toxicity being a relevant aspect of biomaterials was further spread. In 1986, J. Autian retired from the University of Tennessee after he had been Dean of the School of Pharmacy andlaterVice-Chancellor (Health Science Center).
Other groups worldwide became active or enlarged their activities in this field. Standing in for these researchers, only a few can be mentioned here. NIOM (Nordisk Odontologisk Materialprøvning) was founded in 1972 by the Nordic countries in Europe. Its first director was I. Mjör, followed in 1995 by A. Hensten-Pettersen. Like MST, a spectrum of biological test methods was applied, but the activities also included technical and chemical testing. NIOM was partially funded by the Nordic States and partially by industry, which was required to have NIOM approval before they could place their materials on the market in these countries. The great influence of NIOM was based on its legal status as well as on its publication activities. Furthermore, together with our group, much effort was placed on the development of new standards and European legislation.
One of the most active university-based groups was in Connecticut, guided by K. Langeland, with the impetus on pulp/endodontic studies in monkeys. Later, this group was joined by L. Spangberg, introducing the Cr51 method as a cell culture technique into dental materials testing (Spangberg, 1973). H. Stanley at the University of Florida published important studies on pulp reactions to dental filling materials and to pulp capping. The field of biological aspects was now broadened from adverse effects testing to the evaluation of beneficial biological properties, like promoting healing or new tissue formation, an area which today is called tissue engineering.
| SETTING UP STANDARDS |
|---|
|
|
|---|
In 1980, the FDIs "Recommended standard practices for biological evaluation of dental materials" was published under the leadership of K. Langeland. Under the wise guidance of H. Stanley, finally, in 1997, a full standard on the "Preclinical evaluation of biocompatibility of medical devices used in dentistryTest methods for dental materials (ISO 7405)" was finalized (International Organization for Standardization, 1997). Interestingly, international standards on the biocompatibility of biomaterials in general were based to a large extent on the experiences of scientists from dentistry. The result of this work was the ISO 10993 series, which by now is transferred to European standards (EN 30 993-series) havingwithin the EUan almost "law-like" status. ISO 10993 and ISO 7405 complement one another.
| LEGAL REGULATIONS AND PUBLIC DISCUSSIONS |
|---|
|
|
|---|
The transformation of clinical observations and scientific reports into legislation sounds like a real success story of science, directly demonstrating the beneficial impact of research on the quality of life of the population. However, a few dental materials recently being marketed showed biocompatibility problems, e.g., cases of severe pulpal pain, which needed revision of the restoration. This demonstrates the limits of legislation, of pre-clinical testing, and the importance of clinical testing over a given period of time. It also demonstrates that this sort of legislation needs constant revision.
In this context, the biological aspects of dental materials have attracted considerable public concern which cannot be dealt with in detail here, but which is specific to this area of research. Many researchers were involved in public discussions and were members of national and international committees set up by politicians/administrations to define a basis for political decisions, e.g., to forbid, or to restrict, the use of a material by legal regulations. A main problem in this context, which this and other authors observed during these public discussions, is that it is apparently difficult for the lay press to put data from toxicity tests into the right perspective and to critically analyze the data with respect to the health risk of the population. This is considered to be the task of a scientist, and therefore the involvement of scientists in these discussions is necessary.
| NEW STRATEGIES |
|---|
|
|
|---|
In line with the attempts to elucidate the mechanisms, research proceeded from cellular toxic to subtoxic effects. One example is mutagenicity; apparently, components of dental materials, such as TEGDMA or BADGE, may interfere with DNA, a cause mutation which can be transferred to future cell generations (Schweikl et al., 1998; Schweikl and Schmalz, 1999; Geurtsen and Leyhausen, 2001). Other research concentrated on the influence of dental materials and their constituents on inflammation mediators (Schmalz et al., 1998, 2000). This approach seems very interesting to us, because it may show a direct biochemical link between the parameters measured in vitro and clinical effects (inflammation) in vivo. Other groups concentrated on phospholipids and glutathione (Engelmann et al., 2001), on estrogenic effects (Wataha et al., 1999; Hashimoto and Nakamura, 2000), or on heat-shock proteins (Noda et al., 2002). Thus, the influence of materials on cell metabolism has become a topic of research. Close contact with basic science groups, such as pulp and cell biology, are of utmost importance for further developmente.g., using microarray techniques.
Another trend is the increasing tendency to replace animal tests by in vitro cell culture methods. Apparent discrepancies between results from in vitro tests and those from animal or human studies may be overcome by the new design of test methods, taking the in vivo anatomical situation into account in the in vitro situation. One example is the Dentin Barrier test (Tyas, 1977; Meryon et al., 1983; Hanks et al., 1988; Hume, 1988). Through genetic engineering, cells can be constructed that may meet the requirements for a standardized test and which, on the other hand, better represent the in vivo target tissue (Thonemann and Schmalz, 2000). Standardizable test methods are today based on commercially available equipment, which can be combined with three-dimensional cell cultures with constant medium perfusion simulation blood flow (Schuster et al., 2001; Schmalz et al., 2002).
| CONCLUSIONS |
|---|
|
|
|---|
Research on biological aspects of dental materials was possible only as a result of the interdisciplinary approaches of dentists with disciplines like pharmaceutical science, toxicology, chemistry, and biology. Even more, it was shown that the basic problems, strategies for their solution, and the single methods are very similar for biomaterials with both dental and medical applications, which again shows that dentistry is an integral part of the medical scene.
Received June 24, 2002; Accepted July 22, 2002
| REFERENCES |
|---|
|
|
|---|
Autian J (1977). Toxicological evaluation of biomaterials: primary acute toxicity screening program. Artif Organs 1:5360.[Medline]
Autian J, Brewer HJ (1958). The effect on parenteral products of disposable needles. Am J Hosp Pharm 15:313316.
Baume LJ, Holz J, Fiore Donno G (1972). Produits intermediaires dobturation soumis au test biologique normalise [Biological testing of intermediate lining substances]. J Can Dent Assoc 38:1827.
Bergenholtz G, Cox CF, Loesche WJ, Syed SA (1982). Bacterial leakage around dental restorations: its effect on the dental pulp. J Oral Pathol 11:439450.[Medline]
Brannstrøm M, Nyborg H (1971). The presence of bacteria in cavities filled with silicate cement and composite resin materials. Sven Tandläk Tidskr 64:149155.[Medline]
Decup F, Six N, Palmier B, Buch D, Lasfargues JJ, Salih E, et al. (2000). Bone sialoprotein-induced reparative dentinogenesis in the pulp of rats molar. Clin Oral Investig 4:110119.[Medline]
Dillingham EO, Lawrence WH, Autian J, Schmalz G (1983). Acrylate and methacrylate esters: relationship of hemolytic activity and in vivo toxicity. J Biomed Mater Res 17:945957.[Medline]
Engelmann J, Leyhausen G, Leibfritz D, Geurtsen W (2001). Metabolic effects of dental resin components in vitro detected by NMR spectroscopy. J Dent Res 80:869875.
Fasoli G (1924). Silikatzemente und Pulpaveränderungen. Z Stomatol 22:225238.
Geurtsen W, Leyhausen G (2001). Chemical-biological interactions of the resin monomer triethyleneglycol-dimethacrylate (TEGDMA). J Dent Res 80:20462050.
Hanks CT, Craig RG, Diehl ML, Pashley DH (1988). Cytotoxicity of dental composites and other materials in a new in vitro device. J Oral Pathol 17:396403.[Medline]
Hashimoto Y, Nakamura M (2000). Estrogenic activity of dental materials and bisphenol-A related chemicals in vitro. Dent Mater J 19:245262.[Medline]
Hume WR (1988). Methods of assessment in vitro of restorative material cytotoxicity using an intact human dentine diffusion step. Int Endod J 21:8588.[Medline]
International Organization for Standardization (1997). ISO 7405: dentistrypreclinical evaluation of the biocompatibility of medical devices used in dentistrytest methods for dental materials. Geneva: ISO.
Kawahara H, Shiota M, Yamakawa Y (1955). Studies on the effects of dental metals upon the mesenchymal cells in tissue culture. J Osaka Odontol Soc 18:348348.
Klötzer WT, Langeland K (1973). [Testing of materials and methods for crown and bridge prosthesis on animals]. SSO Schweiz Monatsschr Zahnheilkd 83:163244.[Medline]
Langeland LK, Guttuso J, Jerome DR, Langeland K (1966). Histologic and clinical comparison of addent with silicate cements and cold-curing materials. J Am Dent Assoc 72:373385.
Maizumi H, Sauerwein E (1962). Die Wirkung verschiedener Vitalerhaltungs- und Wurzelkanalfüllmittel auf Gewebekulturen. Dtsch Zahnärztl Z 17:16281635.
Meryon SD, Stephens PG, Browne RM (1983). A comparison of the in vitro cytotoxicity of two glass-ionomer cements. J Dent Res 62:769773.
Noda M, Wataha JC, Kaga M, Lockwood PE, Volkmann KR, Sano H (2002). Components of dentinal adhesives modulate heat shock protein 72 expression in heat-stressed THP-1 human monocytes at sublethal concentrations. J Dent Res 81:154162.
Schmalz G (1997). Concepts in biocompatibility testing of dental restorative materials. Clin Oral Investig 1:154162.[Medline]
Schmalz G, Klötzer WT (1986). [DIN-Standard 13930: biological testing of dental materials. I: Concepts of German Standards. Tests for toxicity and tissue irritation for unspecific application]. Dtsch Zahnärztl Z 41:12421247.[Medline]
Schmalz G, Schuster U, Schweikl H (1998). Influence of metals on IL-6 release in vitro. Biomaterials 19:16891694.[Medline]
Schmalz G, Schweikl H, Hiller KA (2000). Release of prostaglandin E2, IL-6 and IL-8 from human oral epithelial culture models after exposure to compounds of dental materials. Eur J Oral Sci 108:442448.[Medline]
Schmalz G, Schuster U, Koch A, Schweikl H (2002). Cytotoxicity of low pH dentin-bonding agents in a dentin barrier test in vitro. J Endod 28:188192.[Medline]
Schuster U, Schmalz G, Thonemann B, Mendel N, Metzl C (2001). Cytotoxicity testing with three-dimensional cultures of transfected pulp-derived cells. J Endod 27:259265.[Medline]
Schweikl H, Schmalz G (1999). Triethylene glycol dimethacrylate induces large deletions in the hprt gene of V79 cells. Mutat Res 438:7178.[Medline]
Schweikl H, Schmalz G, Federlin M (1998). Mutagenicity of the root canal sealer AHPlus in the Ames test. Clin Oral Investig 2:125129.[Medline]
Spangberg L (1973). Kinetic and quantitative evaluation of material cytotoxicity in vitro. Oral Surg Oral Med Oral Pathol 35:389401.[Medline]
Thonemann B, Schmalz G (2000). Immortalization of bovine dental papilla cells with simian virus 40 large T antigen. Arch Oral Biol 45:857869.[Medline]
Tyas MJ (1977). A method for the in vitro toxicity testing of dental restorative materials. J Dent Res 56:12851290.
Wataha JC, Rueggeberg FA, Lapp CA, Lewis JB, Lockwood PE, Ergle JW, et al. (1999). In vitro cytotoxicity of resin-containing restorative materials after aging in artificial saliva. Clin Oral Investig 3:144149.[Medline]
This article has been cited by other articles:
![]() |
M. Yamada, N. Kojima, A. Paranjpe, W. Att, H. Aita, A. Jewett, and T. Ogawa N-acetyl Cysteine (NAC)-assisted Detoxification of PMMA Resin J. Dent. Res., April 1, 2008; 87(4): 372 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. L. Schuh Medical Device Regulations and Testing for Toxicologic Pathologists Toxicol Pathol, January 1, 2008; 36(1): 63 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moharamzadeh, I.M. Brook, R. Van Noort, A.M. Scutt, and M.H. Thornhill Tissue-engineered Oral Mucosa: a Review of the Scientific Literature J. Dent. Res., February 1, 2007; 86(2): 115 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schweikl, G. Spagnuolo, and G. Schmalz Genetic and cellular toxicology of dental resin monomers. J. Dent. Res., October 1, 2006; 85(10): 870 - 877. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |